RemeGen News and Activities

RemeGen is a company listed under the stock ticker 688331 (CN).

View the org chart displaying its 14 main executives

Most searched biographies at RemeGen

• Jianmin Fang, Chief Executive Officer and Chief Scientific Officer
• Weidong Wang, Chairman of the Board
• Yunjin Chen, Independent Non-Executive Director

Popular executive movements at RemeGen

• Michael Shi has joined the company as Chief Medical Officer  (posted on May 19 2026).

Create your alert
to follow the executive moves at RemeGen.

RemeGen has 2,415 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by RemeGen

Social media about RemeGen

• RemeGen on Wikipedia, Google News & Yahoo Finance
• RemeGen on LinkedIn, X (Twitter) & YouTube